How Accenture is using Google Cloud and Wiz to close security blind spots in modern multi-cloud infrastructure
United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 6 minute read Pharma Industry News Atrogi’s ATR-258 breakthrough: muscle-targeted β2-agonist mimics exercise to treat obesity, diabetes, and muscle loss Atrogi’s ATR-258 mimics exercise through skeletal muscle targeting to reduce fat and preserve muscle, redefining obesity and diabetes therapies. bySoujanya RaviJune 23, 2025